NO982987L - Amidinoproteasehemmere - Google Patents

Amidinoproteasehemmere

Info

Publication number
NO982987L
NO982987L NO982987A NO982987A NO982987L NO 982987 L NO982987 L NO 982987L NO 982987 A NO982987 A NO 982987A NO 982987 A NO982987 A NO 982987A NO 982987 L NO982987 L NO 982987L
Authority
NO
Norway
Prior art keywords
amidinoproteasehemmere
compounds
formula
benzamidino
amidino
Prior art date
Application number
NO982987A
Other languages
English (en)
Other versions
NO982987D0 (no
Inventor
Tianbao Lu
Bruce E Tomczuk
Carl Illig
Richard M Soll
Original Assignee
Dimensional Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimensional Pharm Inc filed Critical Dimensional Pharm Inc
Publication of NO982987D0 publication Critical patent/NO982987D0/no
Publication of NO982987L publication Critical patent/NO982987L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/195—Radicals derived from nitrogen analogues of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Amidino- og benzamidinoforbindelser, omfattende forbindelser i formel (I) hvor R -R4, R6-R9, Y, Z, n og m er som angitt i beskrivelsen, såvel som hydrater, solvater eller farmasøytisk akseptable salter derav, som hemmer et antall proteolytiske enzymer ble beskrevet. Det ble også beskrevet en fremgangsmåte for fremstilling av forbindelser med formel (I).
NO982987A 1995-12-29 1998-06-26 Amidinoproteasehemmere NO982987L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US943195P 1995-12-29 1995-12-29
PCT/US1996/020087 WO1997024135A1 (en) 1995-12-29 1996-12-20 Amidino protease inhibitors

Publications (2)

Publication Number Publication Date
NO982987D0 NO982987D0 (no) 1998-06-26
NO982987L true NO982987L (no) 1998-08-28

Family

ID=21737595

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982987A NO982987L (no) 1995-12-29 1998-06-26 Amidinoproteasehemmere

Country Status (19)

Country Link
US (5) US6034127A (no)
EP (1) EP0883405B1 (no)
JP (1) JP2000503010A (no)
KR (1) KR19990076817A (no)
AT (1) ATE260112T1 (no)
BR (1) BR9612360A (no)
CA (1) CA2256309C (no)
CZ (1) CZ206698A3 (no)
DE (1) DE69631692T2 (no)
DK (1) DK0883405T3 (no)
ES (1) ES2213786T3 (no)
HU (1) HUP9902256A3 (no)
IL (1) IL124883A0 (no)
MX (1) MX9805152A (no)
NO (1) NO982987L (no)
NZ (1) NZ326076A (no)
PL (1) PL327986A1 (no)
PT (1) PT883405E (no)
WO (1) WO1997024135A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2213786T3 (es) 1995-12-29 2004-09-01 3-Dimensional Pharmaceuticals, Inc. Inhibidores de la amidino-proteasa.
SE9602646D0 (sv) 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds
TW499412B (en) 1996-11-26 2002-08-21 Dimensional Pharm Inc Aminoguanidines and alkoxyguanidines as protease inhibitors
EP1007037A4 (en) 1997-06-26 2004-10-06 Lilly Co Eli ANTITHROMBOTIC AGENTS
AU8875798A (en) * 1997-08-29 1999-03-22 Proteus Molecular Design Ltd Meta-benzamidine derivatives as serin protease inhibitors
US6740682B2 (en) 1997-08-29 2004-05-25 Tularik Limited Meta-benzamidine derivatives as serine protease inhibitors
ATE438851T1 (de) * 1998-11-20 2009-08-15 Fuso Pharmaceutical Ind Nachweismethode für pankreatitis
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
US6586617B1 (en) 1999-04-28 2003-07-01 Sumitomo Chemical Takeda Agro Company, Limited Sulfonamide derivatives
JP2001026506A (ja) * 1999-04-28 2001-01-30 Takeda Chem Ind Ltd スルホンアミド誘導体
EP1307432A1 (en) 2000-08-04 2003-05-07 3-Dimensional Pharmaceuticals, Inc. Cyclic oxyguanidine protease inhibitors
US6787519B2 (en) * 2000-11-03 2004-09-07 The Regents Of The University Of California Methods of treating disorders related to apoE
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
AU2002256361B2 (en) * 2001-04-24 2008-01-24 Arxy Therapeutics Coumarin derivatives to be used as anticoagulants
HUE025683T2 (hu) 2002-12-03 2016-04-28 Pharmacyclics Llc VIIA faktor inhibitor 2-(2-hidroxi-bifenil-3-il)-1H-benzoimidazol-5-karboxamidin-származékok
MXPA06010899A (es) * 2004-03-25 2006-12-15 Elan Pharm Inc 1,3-diaminopropanos substituidos con 2-amino y 2-tio.
GB0815782D0 (en) * 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815784D0 (en) * 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815781D0 (en) * 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
US8894970B2 (en) * 2010-12-31 2014-11-25 Corridor Pharmaceuticals, Inc. Arginase inhibitors and methods of use thereof
EP2989080A1 (en) * 2013-04-22 2016-03-02 Reuter Chemische Apparatebau KG Process for preparing enantiomerically enriched 3-hydroxymethylpiperidine

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577432A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-phenoxypyrrolidines
CH526535A (de) 1970-02-05 1972-08-15 Sandoz Ag Verfahren zur Herstellung neuer Pyrrolidin-1-carboxamidinderivate
JPS537436B2 (no) * 1974-04-16 1978-03-17
JPS5175042A (ja) * 1974-12-26 1976-06-29 Ono Pharmaceutical Co Guanijinoshibosanamidojudotaino seizohoho
HU177098B (en) * 1979-01-04 1981-07-28 Gyogyszerkutato Intezet Process for producing new peptidyl-n-carboxy-l-arginin-a
US4316899A (en) 1979-08-24 1982-02-23 Beecham Group Limited Chromanone derivatives, a process for their preparation and compositions containing them
US4433152A (en) * 1981-05-25 1984-02-21 Nippon Chemiphar Co., Ltd. Amidinopiperidine derivatives
JPS58194861A (ja) * 1982-05-10 1983-11-12 Nippon Chemiphar Co Ltd 新規ピペリジン誘導体およびその製造法
JPS62145060A (ja) 1985-12-17 1987-06-29 Tanabe Seiyaku Co Ltd ピペラジン誘導体及びその製法
US5039805A (en) * 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
DE3913597A1 (de) 1989-04-25 1990-11-08 Heumann Pharma Gmbh & Co Diazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
TW201303B (no) * 1990-07-05 1993-03-01 Hoffmann La Roche
DE4127404A1 (de) 1991-08-19 1993-02-25 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
ES2165122T3 (es) 1992-02-05 2002-03-01 Boehringer Ingelheim Pharma Nuevos derivados de amidina, su preparacion y utilizacion como medicamentos con efecto antagonista de ltb4.
TW223629B (no) * 1992-03-06 1994-05-11 Hoffmann La Roche
TW257757B (no) * 1993-03-03 1995-09-21 Boehringer Mannheim Gmbh
US5466811A (en) * 1994-07-18 1995-11-14 Merck & Co., Inc. Dioxolenylmethyl carbamates pro moieties for amine drugs
DE4430755A1 (de) * 1994-08-30 1996-03-07 Boehringer Mannheim Gmbh Neue Phosphanoxide, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE4430757A1 (de) * 1994-08-30 1996-03-07 Boehringer Mannheim Gmbh Neue 4-Aminopyridazine, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
ATE229800T1 (de) * 1995-09-29 2003-01-15 Dimensional Pharm Inc Guanidino proteiase inhibitoren
ES2213786T3 (es) 1995-12-29 2004-09-01 3-Dimensional Pharmaceuticals, Inc. Inhibidores de la amidino-proteasa.

Also Published As

Publication number Publication date
AU1432397A (en) 1997-07-28
PT883405E (pt) 2004-06-30
NO982987D0 (no) 1998-06-26
CA2256309A1 (en) 1997-07-10
IL124883A0 (en) 1999-01-26
HUP9902256A1 (hu) 1999-10-28
CA2256309C (en) 2006-08-15
DE69631692D1 (de) 2004-04-01
EP0883405B1 (en) 2004-02-25
WO1997024135A1 (en) 1997-07-10
MX9805152A (es) 1998-10-31
US6281206B1 (en) 2001-08-28
AU706145B2 (en) 1999-06-10
US20010025041A1 (en) 2001-09-27
DK0883405T3 (da) 2004-06-28
US6414020B2 (en) 2002-07-02
JP2000503010A (ja) 2000-03-14
ES2213786T3 (es) 2004-09-01
CZ206698A3 (cs) 1998-11-11
US6034127A (en) 2000-03-07
US6225302B1 (en) 2001-05-01
PL327986A1 (en) 1999-01-04
NZ326076A (en) 1999-02-25
EP0883405A4 (en) 1999-04-28
US6133315A (en) 2000-10-17
KR19990076817A (ko) 1999-10-15
EP0883405A1 (en) 1998-12-16
BR9612360A (pt) 1999-07-13
DE69631692T2 (de) 2004-12-02
HUP9902256A3 (en) 2000-01-28
ATE260112T1 (de) 2004-03-15

Similar Documents

Publication Publication Date Title
NO982987L (no) Amidinoproteasehemmere
NO922113L (no) Kjemiske forbindelser
PL325425A1 (en) Novel 4-(oxyalkoxyphenyl)-3-oxy piperisiden for treating cardiac and recal insufficiency
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
UA7140A1 (uk) Спосіб отримання похідних піридіну
NO996108L (no) 9-oksinerytromycinderivater
NO932159D0 (no) Gallesyrederivater, fremgangsmaate for fremstilling av demog anvendelse av forbindelsene som legemidler
AU6350699A (en) Chemical compounds
AU7697091A (en) Pressure-sensitive, adhesive-backed substrates and method for producing same
DK0699207T3 (da) Mellemprodukt til azithromycin
PL289487A1 (en) Method of producing new aminophenol derivatives
MX9704893A (es) Derivados de lewis x y procesos para producir los mismos.
NO933611L (no) Anti-tumor- og anti-psoriatiske midler
MX9708696A (es) Cefalosporinas antibacterianas.
NZ325235A (en) New phenylamidine derivatives, a process for preparing the same and their use as medicaments
NO981393L (no) Guanidinoproteasehemmere
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
UA8017A1 (uk) Спосіб отримання похідних хінолінкарбонової кислоти
AU2895397A (en) Novel substance library and supramolecular complexes prepared therewith
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
MY117934A (en) Process for the preparation of n-methyl-3-(1-methyl-4- piperidinyl)-1h-indole-5-ethanesulphonamide
AU6985796A (en) Method of producing dihydroxypyrimidine derivatives
AU4842996A (en) Novel platinum (iv) complexes, process for producing the same, and carcinostatic agents containing the same
DE3770359D1 (de) 6-amino-anthracycline, verfahren zu ihrer herstellung und ihre verwendung.
WO1997013776A3 (fr) Nouveaux derives amines de 2', 3' didesoxyglycosides d'epipodophyllotoxine, leur procede de preparation, leur utilisation comme medicament et leur utilisation destinee aux traitements anticancereux

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application